Ocugen is trading 6.12% higher at $0.79, with no clear company-specific catalyst identified. - The stock is up from its November 3 close of $0.75. - Ocugen is scheduled to report third-quarter 2026 results and provide a business update at 8:30 a.m. ET on November 4; the upcoming report alone does not establish the reason for the gain. - U.S. indexes were modestly positive, with moves below 0.5%; volume information was unavailable.